Select year
  • Myriad Genetics Third Quarter 2022 Financial Earnings

    11/01/2022 | 1:30pm PDT / 4:30pm EDT

  • Myriad Genetics Second Quarter 2022 Financial Earnings Call

    08/04/2022 | 1:30pm PDT / 4:30pm EDT

  • BofA Securities 2022 Healthcare Conference

    05/11/2022 | 11:20am PDT / 2:20pm EDT

  • Myriad Genetics First Quarter 2022 Financial Results Conference Call

    05/05/2022 | 1:30pm PDT / 4:30pm EDT

  • Myriad Genetics Names Mark Verratti Chief Commercial Officer, Dale Muzzey Chief Scientific Officer

    04/14/2022 | 8:59pm PDT / 11:59pm EDT

  • 2022 Annual letter to stakeholders

    04/14/2022 | 8:59pm PDT / 11:59pm EDT

  • Cowen Health Care Conference

    03/08/2022 | 6:50am PST / 9:50am EST

  • Myriad Genetics Fourth Quarter 2021 Financial Results Conference Call

    02/24/2022 | 1:30pm PST / 4:30pm EST

  • SVB Leerink Global Healthcare Conference

    02/18/2022 | 8:20am PST / 11:20am EST

  • BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

    02/17/2022 | 9:00am PST / 12:00pm EST

  • 40th J.P. Morgan Healthcare Conference

    01/11/2022 | 11:15am PST / 2:15pm EST